Representative Publications (Journal/Conference): Trainees are underlined. *Corresponding Author.
Aziz MA, Maruf AA, Bolton JM, Kowalec K, Eltonsy S, Leong C. (2026). Early Discontinuation of Antidepressants in Mood and Anxiety Disorders: A Narrative Review of Factors and Strategies to Improve Adherence. Journal of Clinical Psychopharmacology [In Press]
Maruf AA, Leong C, & Aziz MA. (2025). Assessing the 12-Month Persistence of Selective Serotonin Reuptake Inhibitors (SSRIs) in Individuals with Mood, Anxiety, and Related Disorders. Canadian Pharmacists Journal, 158[Suppl]:74.
Tabassum N, Le M, Hasan M, Aziz MA, & *Maruf AA. (2025). Integrating Pharmacogenomics into Pediatric Care: A Scoping Review of Test Counselling, Expectations, Concerns, and Attitudes of Patients and Their Families. European Journal of Human Genetics, 33 (114).
Hasan M, Tabassum N, & *Maruf AA. (2025). BRCA Gene Mutations in the Bangladeshi Population: A Narrative Review. European Journal of Human Genetics, 33 (451).
Aziz MA, Maruf AA, & Leong C. (2025). Persistence Patterns of Antidepressants in Mood, Anxiety, and Related Disorders: A Retrospective Cohort Study. Value in Health, 28(6), S365.
Siu W-S, Maruf AA, Shaheen S-M, McCloud R, Heintz M, McAusland L, Arnold PD, & Bousman CA. (2025). Effect of Individual and Combined Cytochrome P450 Activity Scores on Symptom Improvement and Side Effects in Youth Treated with Sertraline. Clinical and Translational Science. 19(5):e70590. PubMed ID: 42115785.
Lemboye N, Heintz M, Maruf AA, Shaheen S-M, McCloud R, McAusland L, Arnold PD, & Bousman CA. (2026). Characteristics of Initial Pharmacogenetic Testing and Subsequent Physician Referral Behavior in Youth Mental Health. Pharmacogenetics & Genomics. doi: 10.1097/FPC.0000000000000603. PubMed ID: 42010432.
BrownLC, ZaiG, KennedyJL, MüllerDJ, TavakoliE, BousmanC, *MarufAA. (2025). Psychiatric Pharmacogenomic Testing: A Primer for Clinicians. Psychiatr Clin North Am. 48(2):257-264. PubMed ID: 40348416.
Weng-Sam Siu, Maruf AA, Shaheen S-M, McCloud R, Heintz M, McAusland L, Arnold PD & Bousman CA. (2025). Estimating the Frequency of False-Negative Pharmacogenetic Test Results by Self-Reported Ancestry. Clin Pharmacol Ther. PubMed ID: 40287944.
Esteban J, Monnin C, Turcotte D, Maruf AA, Gunderson J, Kedy J, Mosel J, Slaney T, & Chudyk AM. (2025). Protocol for a Scoping Review of Patient Engagement in Pharmacy Practice Research. BMJ Open. 15(3):e089930. PubMed ID: 40081974.
Gerlach S, Maruf AA, Shaheen S-M, McCloud R, Heintz M, McAusland L, Arnold PD & Bousman CA. (2024). Prevalence Estimates of Cytochrome P450 Phenoconversion in Youth Receiving Pharmacotherapy for Mental Health Conditions. Clin Pharmacol Ther. PubMed ID: 39686785.
*Maruf AA, Meagan H, Wondrasek A, Fryza A, Leong C, Kowalec K & Bousman CA. (2024). Knowledge of and Perceptions Toward Pharmacogenomics among Pharmacists in Manitoba, Canada. Pharmacogenomics. PubMed ID: 38506345.
Wondrasek A, Fryza A, Aziz MA, Leong C, Kowalec K, *Maruf AA. (2024). Knowledge, Perceptions, and Attitudes toward Pharmacogenomics among Pharmacists and Pharmacy Students: A Systematic Review. Health Science Reports. 7(1): e1844. PubMed ID:10809028.
Gerlach S, Maruf AA, Shaheen S-M, McCloud R, Heintz M, McAusland L, Arnold PD & Bousman CA. (2024). Effect of CYP2D6 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects among Children and Adolescents Treated with Amphetamines. Pharmacogenetics and Genomics. PubMed ID: 38517706.
McAusland L, Burton CL, Bagnell A, Boylan K, Hatchard T, Lingley-Pottie P, Maruf AA, McGrath P, Newton AS, Rowa K, Schachar RJ, Shaheen S-M, Stewart S, Arnold PD, Crosbie J, Mattheisen M, Soreni N, Stewart SE & Meier S (2024). The genetic architecture of youth anxiety: a study protocol. BMC Psychiatry. 24(1):159. PubMed ID:38395805.
Bharthi K, Zuberi R, Maruf AA, Shaheen S-M, McCloud R, Heintz M, McAusland L, Arnold PD & Bousman CA. (2024). Impact of Cytochrome P450 Genetic Variation on Patient-reported Symptom Improvement and Side Effects among Children and Adolescents Treated with Fluoxetine. Journal of Child and Adolescent Psychopharmacology. 34(1):21-27. Pubmed ID: 38377520.
*Maruf AA & Aziz MA. (2023). The Potential Roles of Pharmacists in the Clinical Implementation of Pharmacogenomics. Pharmacy (Basel). 11(6): 180. PubMed ID: 37987390.
Bousman CA, Maruf AA, Marques DF, Brown LC, Mueller DJ. (2023). Emergence, Implementation, and Future Growth of Pharmacogenomics in Psychiatry: A Narrative Review. Psychological Medicine, Sep 29;1-11. PubMed ID: 37772416.
Mostaid MS, Aziz MA, Maisha JA, Islam MS & *Maruf AA. (2023). A Review of Pharmacogenetic Studies in the Bangladeshi Population. Drug Metabolism and Personalized Therapy, 38(2):123–131. PubMed ID: 36854045.
Brown LC, Stanton JD, Bharthi k, Maruf AA, Müller DJ & Bousman CA. (2022). Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials. Clinical Pharmacology & Therapeutics, 112(6):1303–1317. PubMed ID: 36111494.
Maruf AA & Bousman CA. (2022). Approaches and Hurdles of Implementing Pharmacogenetic Testing in Mental Health Care. Psychiatry and Clinical Neurosciences Reports. 1(2):e26. Pubmed ID: 38868642.
Jessel CD, Maruf AA, Oomen A, Arnold PD & Bousman CA. (2021). Pharmacogenetic Testing Knowledge and Attitudes among Pediatric Psychiatrists and Pediatricians in Alberta, Canada. The Journal of the Canadian Academy of Child and Adolescent Psychiatry. 31(1):18-27. PubMed ID: 35251193.
Stein K, Maruf AA, Müller DJ, Bishop JR & Bousman CA. (2021). Serotonin Transporter Genetic Variation and Antidepressant Response and Tolerability: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine. 11(12), 1334. PubMed ID: 34945806.
*Maruf AA, Poweleit EAB, Brown LC, Strawn JR & Bousman CA. (2021). Systematic Review and Meta-Analysis of L-methylfolate Augmentation in Depressive Disorders. Pharmacospychiatry, 55(3):139-147. PubMed ID: 34794190.
Maruf AA, Stein K, Arnold PD, Aitchison K, Müller DJ & Bousman C. (2020). CYP2D6 and Antipsychotic Treatment Outcomes in Children and Youth: A Systematic Review. Journal of Child and Adolescent Psychopharmacology. 31(1):33-45. PubMed ID: 33074724.
Liu C, Maruf AA & Bousman C. (2020). Reporting of Clozapine-Induced Gastrointestinal Hypomotility and Factors Associated with Fatal Outcomes in Canada. Psychiatry Research. 290:113048. PubMed ID: 32474068.
Maruf AA, Fan M, Arnold PD, Müller DJ, Aitchison K & Bousman C. (2020). Reply to Dawes and Colleagues. Canadian Journal of Psychiatry. PubMed ID: 32425056.
Maruf AA, Fan M, Arnold P, Müller DJ, Aitchison K & Bousman C. (2020). Review of Pharmacogenetic Testing Options Relevant to Psychiatry in Canada. Canadian Journal of Psychiatry. Feb 17:706743720904820. PubMed ID: 32064906.
Maruf AA, Greenslade A, Arnold PD & Bousman C. (2019). Antidepressant Pharmacogenetics in Children and Adolescent: A Systematic Review. Journal of Affective Disorder. 254:98-108. *Co-first author. PubMed ID: 31112844.
Bousman CA, Maruf AA & Müller DJ. (2019). Towards The Integration of Pharmacogenetics in Psychiatry: A Minimum, Evidence-Based Genetic Testing Panel. Current Opinion in Psychiatry, 32(1):7-15. PubMed ID: 30299306.